5 latest biotechnology breakthroughs, from genome sequencing to microbiome manipulation, revolutionizing medicine, ...

Growth in the blue biotechnology market can be attributed to many segments, one of which is the application segment comprising of pharmaceuticals, F&B, and others.

Yet, perhaps not surprisingly, some small biotechnology companies and independent inventors have voiced concerns about the new publication rules, their principal concern being that the loss of ...

Viral vectors are engineered viruses used to deliver genetic material into cells for gene therapy, vaccine development, and biotechnology research, offering high transduction efficiency and sustained ...

Artificial intelligence (AI) and laboratory automation have already shown promise for revolutionizing research in biotechnology. These technologies offer tremendous opportunities to be leveraged for ...

About Accutar Biotechnology, Inc. Accutar is a clinical stage biotech company focused on AI-empowered drug discovery, and its application to the discovery and development of clinically ...

Potential biotech and health applications with new knowledge on bacteria and viruses Peer-Reviewed Publication University of Otago image: This is Dr. Simon Jackson. view more Credit: University of ...

Algal Biotechnology for Fuel Applications gives the reader a comprehensive picture of the industrial use of algae for generating power. This book informs readers about the existence of alternative ...

Using the Derwent Biotechnology Abstracts database for the period from 1992–1996, we examined variables including the number of patent applications, country of origin, distribution between large ...

Biotechnology’s applications have the potential to alter geopolitical dynamics significantly. China has understood this reality for some time.

China will evaluate eight pending U.S. agricultural biotechnology product applications by the end of May, potentially opening the door for sales by Dow AgroSciences, DuPont Pioneer, Monsanto, and ...

Beijing Luzhu Biotechnology Co., Ltd. Class H ( ($HK:2480) ) has provided an update. Beijing Luzhu Biotechnology Co., Ltd. reported its interim ...